Fibrocell to Present at Phacilitate Leaders World 2019

EXTON, Pa., Jan. 16, 2019 (GLOBE NEWSWIRE) — Fibrocell Science, Inc. (NASDAQ: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today announced that John Maslowski, President and Chief Executive Officer, will present at Phacilitate Leaders World 2019 on Wednesday, January 23 at 2:05 pm EST in […]

Read more

Phacilitate Leaders World and World Stem Cell Summit Announce New Updates: Visionary Speakers, Programs and Agenda

Nighttime partnering cocktail event Daytime seminars, meetings and trainings #WSCS2019 and #PLW2019 January 22-25, 2019, Hyatt Regency Miami Miami, FL, Jan. 17, 2019 (GLOBE NEWSWIRE) — The co-located Phacilitate Leaders World and World Stem Cell Summit (WSCS) are proud to announce new updates to the world’s largest advanced therapies partnering event. There is still time […]

Read more
Emily Whitehead Foundation and Phacilitate to Hold Yacht Party Fundraiser at Phacilitate Leaders World in Miami

Emily Whitehead Foundation and Phacilitate to Hold Yacht Party Fundraiser at Phacilitate Leaders World in Miami

PHILIPSBURG, Pa. (Nov. 20, 2018) – In an effort to bring more awareness to pediatric cancer immunotherapy research, the Emily Whitehead Foundationand London-based Phacilitate are joining together to hold a one of a kind fundraising event in Miami, Florida on January 24, 2019. The exclusive event will take place during Phacilitate Leaders World iconic yacht […]

Read more

Avalon GloboCare CEO David Jin, M.D., Ph.D. to Chair and Speak at the Plenary Session of the 14th Annual World Stem Cell Summit

Plenary Session and Presentation entitled “Status of Cellular Therapy and Regenerative Medicine in China” FREEHOLD, N.J., Jan 15, 2019 (GLOBE NEWSWIRE via COMTEX) — Avalon GloboCare Corp. AVCO, +0.00% a leading global developer of cell-based technologies, announced today that its President and Chief Executive Officer, David Jin, M.D., Ph.D., will chair and speak at the […]

Read more

Marker Therapeutics to Present at the Phacilitate Leaders World & World Stem Cell Summit 2019

HOUSTON, Jan. 17, 2019 /PRNewswire/ — Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced that its President and CEO, Peter L. Hoang, will present a corporate overview at the upcoming Phacilitate Leaders World & World Stem […]

Read more

Stem cell research at Sanford Health set for next phase

Sanford Health is a contributing partner of the 2019 World Stem Cell Summit. Philanthropist Denny Sanford received the RMF Stem Cell Action “Leadership” Award, at the 2013 World Stem Cell Summit in San Diego. It was his vision and focused philanthropy that brought forth Sanford Health, now one of the largest health systems in the […]

Read more

What do you think of this newspaper advertisement for Stem Cells?

Who owns the brand “stem cells” ? Lofty scientific societies, such as the International Society for Stem Cell Research (ISSCR)? How about medical associations like the American Society for Plastic Surgeons (ASPS) or members of the International Federation for Adipose Therapeutics and Science (IFATS)? Or perhaps the term “stem cells” is generic- to be utilized […]

Read more
Finding a solution to the afflictions of aging- LONGEVERON

Finding a solution to the afflictions of aging – LONGEVERON

Florida-based company Longeveron’s goal is to provide a biological solution for aging-related diseases, and is dedicated to developing safe cell-based therapeutics to revolutionize the aging process and improve quality of life. The company’s research focus areas include Alzheimer’s disease, Aging Frailty, and the Metabolic Syndrome. Important MSC studies are advancing. Meet the leadership of Longeveron […]

Read more
Longeveron Receives Prestigious NIH Small Business Innovation Research Grant

Longeveron Receives Prestigious NIH Small Business Innovation Research Grant

Grant will be applied to Longeveron’s Aging Frailty stem cell research MIAMI, Oct. 18, 2018 – Longeveron LLC, a biopharmaceutical company that develops stem cell therapies for aging-related diseases, announced that the company has been awarded a $3.8 million Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) for its research […]

Read more
Regenerative Medicine Manufacturing Society (RMMS) to hold Membership Meeting in Miami- part of pre-conference activities at World Stem Cell Summit & Phacilitate Leaders World

Regenerative Medicine Manufacturing Society (RMMS) to hold Membership Meeting in Miami- part of pre-conference activities at World Stem Cell Summit & Phacilitate Leaders World

Miami, Fla. – Jan. 7, 2019 – The Regenerative Medicine Manufacturing Society (RMMS) returns to the Phacilitate Leaders World and World Stem Cell Summit for its second annual membership meeting to be held on the pre-conference day in Miami, Fl. The meeting, which will take place on Jan. 22 from 2:30 p.m. to 5:15 p.m. […]

Read more